At 11.5% CAGR, Asia Pacific Aesthetic Medical Devices Market is Projected to be Worth US$ 9,938.72 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific aesthetic medical devices market was valued at US$ 4,158.02 million in 2023 and is expected to reach US$ 9,938.72 million by 2031, registering a CAGR of 11.5% from 2023 to 2031. Surge in adoption of minimally invasive and non-invasive aesthetic procedures and technological advancements associated with medical aesthetic devices are among the critical factors attributed to drive the Asia Pacific aesthetic medical devices market growth.

Minimally invasive procedures offer patients various benefits, including reduced downtime, lesser scarring, lower risks, limited stress, better patient satisfaction, and quicker recovery times compared to traditional invasive surgeries. This shift toward minimally invasive approaches is driven by several factors, such as technological advancements in aesthetic devices, increasing patient preference for nonsurgical options, and advancements in medical research and techniques. Moreover, the rise of minimally invasive procedures aligns with a broader societal shift toward wellness, natural-looking enhancements, and personalized treatment approaches. Patients seeking aesthetic treatments are often drawn to minimally invasive options that provide subtle enhancements and visible results without the need for extensive surgical interventions.

The modern concept of natural and harmonious rejuvenation is based on a comprehensive, three-dimensional, multi-layered approach that combines several active ingredients and techniques in surgical procedures such as skin relaxation, volume enlargement, repositioning, reshaping, surface renewal, and skin tightening, depending on the specific patient needs. The appearance of the skin is considered an important factor to check an individual’s well-being and health; as a result, the number of aesthetic procedures performed worldwide is increasing steadily. Further, nonsurgical procedures include facial injections and cryolipolysis, among others. These short procedures help correct facial lines, wrinkles, cellulite reduction, and unwanted fat reduction with minimal side effects. The International Society of Aesthetic Plastic Surgery (ISAPS) defines a nonsurgical cosmetic procedure as an effective and safe procedure for those who are willing to undergo subtle enhancement and surgical result enhancement with lower recovery periods; these procedures often do not require extensive training, unlike surgical procedures that are associated with greater risks. According to ISAPS estimates, the number of treatments carried out by plastic surgeons globally is expected to rise by 11.2% by 2022, with approximately 14.9 million surgical procedures and 18.8 million nonsurgical procedures. With the proliferation of the medical aesthetics industry, competition is also inevitably increasing among beauty clinics specializing in surgical cosmetic procedures as well as other beauty service providers such as salons. Thus, the surge in the adoption of minimally invasive and noninvasive aesthetic procedures drives the growth of the aesthetic medical market.

On the contrary, risks and complications associated with procedures and stringent safety regulations hamper the growth of Asia Pacific aesthetic medical devices market.

Based on technology, the Asia Pacific aesthetic medical devices market is divided into laser-based, light-based, electromagnetic energy-based, ultrasound-based, cryolipolysis, suction-based, and plasma energy-based. The laser-based segment held 24.5% market share in 2023, amassing US$ 1,019.75 million. It is projected to garner US$ 2,488.60 million by 2031 to register 11.9% CAGR during 2023–2031.

In terms of application, the Asia Pacific aesthetic medical devices market is segmented into facial skin resurfacing, photorejuvenation, hair removal, fat reduction and body contouring, skin tightening, cellulite reduction, feminine rejuvenation, tattoos and pigmentation, acne and acne scars, vascular lesions, and others. The acne and acne scars segment held 18.7% share of Asia Pacific aesthetic medical devices market in 2023, amassing US$ 777.79 million. It is anticipated to garner US$ 1,786.98 million by 2031 to expand at 11.0% CAGR during 2023–2031.

By end user, the Asia Pacific aesthetic medical devices market is divided dermatology and cosmetic clinics, hospitals and clinics, medical spas, and home use. The dermatology and cosmetic clinics segment held 37.1% share of Asia Pacific aesthetic medical devices market in 2023, amassing US$ 1,540.80 million. It is projected to garner US$ 3,802.16 million by 2031 to expand at 12.0% CAGR from 2023 to 2031.

Based on country, the Asia Pacific aesthetic medical devices market is categorized into China, India, Japan, South Korea, Australia, Indonesia, Singapore, Malaysia, Taiwan, Thailand, Vietnam, and the Rest of Asia Pacific. Our regional analysis states that China captured 26.4% share of Asia Pacific aesthetic medical devices market in 2023. It was assessed at US$ 1,096.98 million in 2023 and is likely to hit US$ 2,710.45 million by 2031, registering a CAGR of 12.0% during 2023–2031.

Key players operating in the Asia Pacific aesthetic medical devices market are Merz Pharma GmbH & Co KGaA, Bausch Health Companies Inc, Lumenis Be Ltd, Venus Concept Inc, Cutera Inc, Fotona, InMode, Cynosure, LLC, and Asclepion Laser Technologies GmbH, among others.

• In February 2021, Asclepion Laser Technologies successfully introduced the new nano laser range: The NanoStar Family. The NanoStar family includes three new q-switch laser systems in three separate devices. A ruby laser (694 nm), a Nd:YAG laser (1,064 nm + 532 nm) and a combined device with all of the mentioned wavelengths including the innovative mixed-technology, giving perfect conditions for every need. The family uses the well-known Q-qwitched technology, which allows for treatment of tattoos, pigments and others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com